Intuitive Surgical, Inc.
ISRG Healthcare Medical Instruments & Supplies
Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024. In the quarter to June 2026, revenue grew 18.5%, EPS grew 25.5% and free cash flow grew 69.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for five consecutive years, operating cash flow growth for three.
Follow ISRG
Intuitive Surgical, Inc. (ISRG) Operating cash flow
Intuitive Surgical, Inc.'s operating cash flow for fiscal 2025 was $3.0B, up 25.5% from $2.4B in fiscal 2024. Over the twelve months to 30 June 2026 it was $3.7B. Over the past ten years it has ranged from $806.2M (fiscal 2015) to $3.0B (fiscal 2025) — the current reading is the highest in ten years. Operating cash flow has risen for 3 consecutive fiscal years. Intuitive Surgical, Inc. ranks 2nd of 54 Medical Instruments & Supplies companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $3.0B | 25.49% |
| FY2024 | $2.4B | 33.15% |
| FY2023 | $1.8B | 21.67% |
| FY2022 | $1.5B | (28.65%) |
| FY2021 | $2.1B | 40.72% |
| FY2020 | $1.5B | (7.10%) |
| FY2019 | $1.6B | 36.65% |
| FY2018 | $1.2B | 2.25% |
| FY2017 | $1.1B | 5.23% |
| FY2016 | $1.1B | 34.83% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | $1.1B | 16.35% |
| Mar 2026 | $911.9M | 2.17% |
| Dec 2025 | $892.5M | 6.12% |
| Sep 2025 | $841.0M | 17.56% |
| 42 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| BDX Becton, Dickinson and Company compare | $4.0B |
| ISRG Intuitive Surgical, Inc. | $3.7B |
| MDLN Medline Inc. compare | $3.1B |
| ALC Alcon compare | $2.3B |
| RMD ResMed Inc. compare | $1.8B |
| BAX Baxter International Inc. compare | $1.3B |
| WST West Pharmaceutical Services, Inc. compare | $662.2M |
| SOLV Solventum Corporation compare | $209.0M |
| RGEN Repligen Corporation compare | $134.9M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on ISRG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement